Reflection on a Breathing Technique "Nose-mouth-nose”. Can it Save Lives?
Carlos Sánchez Fernández de la Vega*
Galician Health Service, Primary Care, SERGAS, Lugo, Spain
*Corresponding Author: Carlos Sánchez Fernández de la Vega, Galician Health Service, Primary Care, SERGAS, Lugo, Spain.
Received: February 27, 2022; Published: March 11, 2022
This is a breathing technique, which consists of inhaling air we exhale, CO2-enriched air. We create a camera with our hands, for inhaling through the nose, the air exhaled through the mouth. When practicing this technique, due to its mucolytic effect, we avoid the use of nasal decongestants in colds. On the other hand, the viral load in the nostrils can decrease, by the action of nitric oxide, generated in the sinuses, and the mucolytic effect of exhaled air enriched with CO2. The anti-viricidal properties of CO2, can explain these results. Can this breathing technique be used as a nasal decongestant, preventing viral respiratory infections? The article “Can Influenza viruses be inactivated by a nose-mouth-nose breathing technique? was published in July 2020. This manuscript was based on the practice of the technique, by me and some patients, when feeling symptoms such as nasal obstruction, cough, and sneezing. When practicing the technique, we did not develop flu symptoms and, if they appeared, the symptomatology was very few days. They solve their own colds, practicing the technique. Before the pandemic began, we were a few people who practiced it, now we are more and, until now, those who have done it correctly, have not been infected. Of course, we have followed each of the indicated health guidelines to prevent the spread of the virus, including vaccination, since it is not possible to demonstrate, that the technique prevents infection by SARS-CoV-2. The clinical case reported, should make us reflect on the usefulness of the technique. A man of 83 years, who practiced and practices this breathing technique, with the third dose of vaccination, suffers from bacterial pneumonia at the peak of the sixth wave of the pandemic.
Keywords: Pneumonia; Obstruction Nasal; Nasal Decongestants; Virus; Upper Respiratory Tract
- Sánchez Fernández de la Vega Carlos. “Nasal breathing technique in nasal airway obstruction”. Viral infections in upper respiratory tract. Conference: 20th IFOS WORLD CONGRESS, June 2013, Seoul, Korea (2013).
- , et al. “Benefits, limits and danger of ephedrine and pseudoephedrine as nasal decongestants”. European Annals of Oto-rhino-laryngology, Head and Neck Diseases 132.1 (2015): 31-34.
- Martirosyan V., et al. “Carbon dioxide as a microbial toxicity enhancer of some antibacterial agents: a new potential water purification tool”. ISRN Biophysics 2012 (2012): 906761.
- Gillian Pocock., et al. Human Physiology (2013): 454.
- Alaa MM El-Betany., et al. “Humidified Warmed CO2 Treatment Therapy Strategies Can Save Lives with Mitigation and Suppression of SARS-CoV-2 Infection: An Evidence Review” (2020).
- Golding-Wood P. “The surgery of nasal allergy”. International Rhinology (1963): 188-193.
- Knipping S., et al. “Regulation der respiratorischen Nasenschleimhaut”. HNO 52 (2004): 471-490.
- Figueroa JM., et al. “Innervation of nasal turbinate blood vessels in rhinitic and nonrhinitic children”. American Journal of Respiratory and Critical Care Medicine 157 (1998): 1959-1966.
- Knipping S. “Untersuchungen zur regulation der seromukösen Drüsen der respiratorischen Nasenschleimhaut des Menschen”. Halle (Saale). Martin-Luther- Universität (2004).
- Baraniuk JN. “Neuropeptides”. American Journal of Rhinology 12 (1998): 9-16.
- Telles S., et al. “Breathing through a particular nostril can alter metabolism and autonomic activities”. Indian Journal of Physiology and Pharmacology 2 (1994): 133-137.
- Sarin S., et al. “The role of the nervous system in rhinitis”. The Journal of Allergy and Clinical Immunology 118 (2006): 999-1016.
- Eliezer M., et al. “Sudden and complete olfactory loss function as a possible symptom of COVID-19”. JAMA Otolaryngology–Head and Neck Surgery (2020).
- Lechien JR., et al. “Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): A multicenter European study”. European Archives of Oto-Rhino-Laryngology 8 (2020): 2251-2261.
- Speth MM., et al. “Olfactory dysfunction and sinonasal symptomatology in COVID-19: Prevalence, severity, timing and associated characteristics”. Otolaryngology–Head and Neck Surgery 1 (2020): 114-120.
- Hopkins C., et al. “Early recovery following new onset anosmia during the COVID-19 pandemic - An observational cohort study”. Journal of Otolaryngology - Head and Neck Surgery 1 (2020): 26.
- Moein ST., et al. “Smell dysfunction: A biomarker for COVID-19”. International Forum of Allergy and Rhinology 8 (2020): 944-950.
- C Serrano., et al. “Oxido nitrico nasal. Revision. C. Óxido nítrico nasal. Revisión”. Archivos de Bronconeumología 5 (2004): 222-230.
- Sánchez Fernández de la Vega Carlos. “Can Influenza viruses be inactivated by a “nose-mouth-nose” breathing technique?” International Journal of Information Research and Review7 (2020): 6973-6975.
- Garrido Sanchis A., et al. “Virus and bacteria inactivation by CO2 bubbles in solution”. NPJ Clean Water5 (2019).
- Sana Jamshald. “Evidence for cure of flu through nose breathing”. International Journal of Advance Research IJOAR, org. (2013).